Xuemin He

Xuemin He

Auto-generated profile, based on publicly available information

Xuemin He

Department of Endocrinology and Metabolic Diseases, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2024 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
XHXuemin He
Xuemin He
SWSiying Wen
Siying Wen
XTXixiang Tang
Xixiang Tang
ZWZheyao Wen
Zheyao Wen
RZRui Zhang
Rui Zhang
YCYanming Chen
Yanming Chen
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) protect against diabetic cardiovascular diseases and nephropathy. However, their activity in diabetic retinopathy (DR) remains unclear. Our retrospective cohort study involving 1626 T2DM patients revealed superior efficacy of GLP-1 RAs in controlling DR compared to other glucose-lowering medications, suggesting their advantage in DR treatment. By single-cell RNA-sequencing analysis and immunostaining, we observed a high expression of GLP-1R in retinal endothelial cells, which was down-regulated under diabetic conditions. Treatment of GLP-1 RAs significantly restored the receptor expression, resulting in an improvement in retinal degeneration, vascular tortuosity, avascular vessels, and vascular integrity in diabetic mice. GO and GSEA analyses further implicated enhanced mitochondrial gene translation and mitochondrial functions by GLP-1 RAs. Additionally, the treatment attenuated STING signaling activation in retinal endothelial cells, which is typically activated by leaked mitochondrial DNA. Expression of STING mRNA was positively correlated to the levels of angiogenic and inflammatory factors in the endothelial cells of human fibrovascular membranes. Further investigation revealed that the cAMP-responsive element binding protein played a role in the GLP-1R signaling pathway on suppression of STING signaling. This study demonstrates a novel role of GLP-1 RAs in the protection of diabetic retinal vasculature by inhibiting STING-elicited inflammatory signals.

19 May 2025 in Biomaterials
Verified
Journal Article
Closed access
SWSiying Wen
Siying Wen
XHXuemin He
Xuemin He
JWJiachen Wang
Jiachen Wang
ZWZheyao Wen
Zheyao Wen
HAHeying Ai
Heying Ai
YCYanming Chen
Yanming Chen